Oleg I. Kiselev
Saint Petersburg, SPE, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1.
Journal: Vaccine
Published: December 17, 2018
ANTIVIRAL ACTIVITY OF THE DIHYDROQUERCETIN DURING THE COXSACKIEVIRUS B4 REPLICATION IN VITRO
Journal: Voprosy virusologii
Published: May 06, 2016
Oncolytic potential of recombinant influenza A virus vectors on a model of malignant glioma in vivo
Journal: Voprosy onkologii
Published: January 01, 2016
CHRONIC HEPATITIS WITH DOUBLE B/C INFECTION: VIROLOGICAL, CLINICAL, MORPHOLOGICAL CHARACTERISTICS.
Journal: Klinicheskaia meditsina
Published: January 01, 2016
Comparison of the influenza epidemics in Russia caused by the pandemic virus A(H1N1)pdm09 within the period from 2009 to 2013
Journal: Voprosy virusologii
Published: August 19, 2015
Adenosine A2A receptor as a drug target for treatment of sepsis
Journal: Molekuliarnaia biologiia
Published: August 16, 2015
Discovery of a new class of antiviral compounds: camphor imine derivatives.
Journal: European journal of medicinal chemistry
Published: August 10, 2015
Interleukin-24 inhibits influenza A virus replication in vitro through induction of toll-like receptor 3 dependent apoptosis.
Journal: Antiviral research
Published: May 12, 2015
Clinical efficacy of arbidol (umifenovir) in the therapy of influenza in adults: preliminary results of the multicenter double-blind randomized placebo-controlled study ARBITR
Journal: Terapevticheskii arkhiv
Published: April 01, 2015
Last Updated: 09/26/2026